Bionano Genomics Inc has a consensus price target of $5.63, established from looking at the 14 latest analyst ratings. The last 3 analyst ratings were released from Scotiabank, Maxim Group, and BTIG on March 7, 2024, November 13, 2023, and August 10, 2023. With an average price target of $5.33 between Scotiabank, Maxim Group, and BTIG, there's an implied 592.64% upside for Bionano Genomics Inc from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
03/07/2024 | BNGO | Buy Now | Bionano Genomics | $0.77 | 679.22% | Scotiabank | Sung Ji Nam | $7 → $6 | Maintains | Sector Outperform | Get Alert |
11/13/2023 | BNGO | Buy Now | Bionano Genomics | $0.77 | — | Maxim Group | Jason McCarthy | — | Downgrade | Buy → Hold | Get Alert |
08/10/2023 | BNGO | Buy Now | Bionano Genomics | $0.77 | 1198.7% | BTIG | Mark Massaro | $2 → $10 | Maintains | Buy | Get Alert |
05/25/2023 | BNGO | Buy Now | Bionano Genomics | $0.77 | 127.27% | EF Hutton | — | → $17.5 | Initiates | → Buy | Get Alert |
05/18/2023 | BNGO | Buy Now | Bionano Genomics | $0.77 | 159.74% | BTIG | Mark Massaro | $30 → $20 | Maintains | Buy | Get Alert |
04/24/2023 | BNGO | Buy Now | Bionano Genomics | $0.77 | 289.61% | BTIG | Mark Massaro | $30 → $30 | Maintains | Buy | Get Alert |
03/10/2023 | BNGO | Buy Now | Bionano Genomics | $0.77 | 289.61% | BTIG | Mark Massaro | → $30 | Maintains | Buy | Get Alert |
02/06/2023 | BNGO | Buy Now | Bionano Genomics | $0.77 | 1068.83% | Oppenheimer | Francois Brisebois | $120 → $90 | Maintains | Outperform | Get Alert |
02/05/2023 | BNGO | Buy Now | Bionano Genomics | $0.77 | 354.55% | BTIG | Mark Massaro | $35 → $35 | Maintains | Buy | Get Alert |
01/05/2023 | BNGO | Buy Now | Bionano Genomics | $0.77 | 419.48% | Scotiabank | Sung Ji Nam | → $40 | Initiates | → Sector Outperform | Get Alert |
12/12/2022 | BNGO | Buy Now | Bionano Genomics | $0.77 | 354.55% | BTIG | Mark Massaro | → $35 | Assumes | → Buy | Get Alert |
07/18/2022 | BNGO | Buy Now | Bionano Genomics | $0.77 | 1458.44% | Oppenheimer | Francois Brisebois | → $120 | Assumes | → Outperform | Get Alert |
04/07/2022 | BNGO | Buy Now | Bionano Genomics | $0.77 | 809.09% | BTIG | Sung Ji Nam | $100 → $70 | Maintains | Buy | Get Alert |
06/16/2021 | BNGO | Buy Now | Bionano Genomics | $0.77 | 1198.7% | BTIG | Sung Ji Nam | — | Initiates | → Buy | Get Alert |
The latest price target for Bionano Genomics (NASDAQ: BNGO) was reported by Scotiabank on March 7, 2024. The analyst firm set a price target for $6.00 expecting BNGO to rise to within 12 months (a possible 679.22% upside). 5 analyst firms have reported ratings in the last year.
The latest analyst rating for Bionano Genomics (NASDAQ: BNGO) was provided by Scotiabank, and Bionano Genomics maintained their sector outperform rating.
There is no last upgrade for Bionano Genomics.
The last downgrade for Bionano Genomics Inc happened on November 13, 2023 when Maxim Group changed their price target from N/A to N/A for Bionano Genomics Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Bionano Genomics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Bionano Genomics was filed on March 7, 2024 so you should expect the next rating to be made available sometime around March 7, 2025.
While ratings are subjective and will change, the latest Bionano Genomics (BNGO) rating was a maintained with a price target of $7.00 to $6.00. The current price Bionano Genomics (BNGO) is trading at is $0.77, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.